Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations
Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.